1. Ahima RS, Osei SY. Adipokines in obesity. Front Horm Res 2008; 36: 182–197.
2. Ashby RL, Adams JE, Roberts SA et al. The muscle-bone unit of peripheral and central skeletal sites in children and young adults. Osteoporos Int 2011; 22: 121–132.
3. Baldock PA, Alison S, Macdonald MM et al. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways. J Bone Miner Res 2006; 21: 1600–1607.
4. Barbour KE, Zmuda JM, Boudreau R et al. Adipokines and the risk of fracture in older adults. J Bone Miner Res 2011; 26: 1568–1576.
5. Bartell SM, Isales CM, Baile CA et al. CART deficiency increases body weight but does not alter bone strength. J Musculoskelet Neuronal Interact 2008; 8: 146–153.
6. Beranova L, Sedláčkova D, Konečná J et al. Neuropeptide Y, ghrelin and leptin plasma levels in anorexia nervosa patients and their changes during six-week refeeding. Vnitř Lék 2009; 55: 925–928.
7. Bonnet N, Pierroz DD, Ferrari SL. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis. J Musculoskelet Neuronal Interact 2008; 8: 94–104.
8. Cannon JG, Cortez-Cooper M, Meaders E et al. Follicle-stimulating hormone, interleukin-1, and bone density in adult women. Am J Physiol Regul Integr Comp Physiol 2010; 293: R790–R798.
9. Elefteriou F. Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 2008; 473: 231–236.
10. Fairbrother UL, Tankó LB, Halley AJ et al. Leptin receptor genotype at Gln223Arg is associated with body composition, BMD, and vertebral fracture in postmenopausal Danish women. J Bone Miner Res 2007; 22: 544–550.
11. Fonseca-Alaniz MH, Takada J, Alfonso-Vale MI et al. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J) 2007; 83 (Suppl 5): S192–S203.
12. Fricke O, Beccard R, Semler O et al. Analyse of muscular mass and function: the impact on bone mineral density and peak muscle mass. Pediatr Nephrol 2010; 25: 2393–2400.
13. Fricke O, Schoenau E. The “muscle-bone unit”: probing the relevance of mechanical signale for bone development in children and adolescents. Growth Horm IGF Res 2007; 17: 1–9.
14. Golden NH, Carlson JL. The pathophysiology of amenorrhoea in the adolescent. Ann NY Acad Sci 2008; 1135: 163–178.
15. Grundberg E, Brändström H, Ribom EL et al. Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur J Endocrinology 2004; 150: 323–328.
16. Hamrick MW, Ferrari SL. Leptin and the sympathetic connection of fat to bone. Osteoporosis Int 2008; 19: 905–912.
17. Hasselstrøm H, Karlson KM, Hansen SE et al. Sex differences in bone size and bone mineral density before puberty. The Copenhagen Schoul Child Intervention Study (CoSCIS). Calcif Tissue Int 2006; 79: 7–14.
18. Iacobellis G, Iorio M, Napoli N et al. Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome. J Endocrinol Invest 2011; 34: e12–5 (Epub 2010).
19. Jürimäe J, Jürimäe T, Leppik A et al. The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab 2008; 26: 618–623.
20. Kaplowitz PB. Link between body fat and timing of puberty. Pediatrics 2008; 121: S208–S217.
21. Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin – the classical, resistin – the controversial, adiponectin – the promissing, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 525–546.
22. Krsek M, Rosická M, Haluzik M et al. The changes in serum ghrelin levels and their relationship to IGF-I, its binding proteins and leptin in women patiens with anorexia nervosa. Vnitř Lék 2002; 48: 948–951.
23. Lac G, Cavalie H, Ebal E et al. Effects of a high fat diets on bone of growing rats. Correlations between visceral fat, adiponectin and bone mass density. Lipids Health Dis 2008; 7: 16.
24. Lerner UH, Persson E. Osteotropic effects by the neuropeptides calcitonin gene-related peptide, substance P and vasoactive intestinal peptide. J Musculoskelet Neuronal Interact 2008; 8: 154–165.
25. Liu LF, Shen WJ, Zhang ZH et al. Adipocytes decrease Runx2 in osteoblastic cells: roles of PPARγ and adiponectin. J Cell Physiol 2010; 225: 837–845.
26. MacDonald H, Kontulainen S, Petit M et al. Bone strength and its determinants in pre- and early pubertal boys and girls. Bone 2006; 39: 598–608.
27. Morelli A, Marini M, Mancina R et al. Sex steroids and leptin regulates the “first Kiss” (KiSS 1/G-protein-coupled receptor 54 system) in human gonadotropin-releasing-hormone-secreting neuroblasts. J Sex Med 2008; 5: 1097–1113.
28. Mukherjee A, Murray RD, Shaket SM. Impact of growth hormone status on body composition and the skeleton. Horm Res 2004; 62 (Suppl 3): 35–41.
29. Parfitt AM. The attainment of peak bone mass: What is the relationship between muscle growth and bone growth? Bone 2004; 34: 767–770.
30. Peng XD, Xie H, Zhao Q et al. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 2008; 387: 31–35.
31. Pludowski P, Lebiedowski M, Olszaniecka M et al. Idiopathic juvenile osteoporosis – an analysis of the muscle-bone relationship. Osteoporosis Int 2006; 17: 1681–1690.
32. Rauch F, Bailey DA, Barter-Jones A et al. The “muscle-bone unit” during the pubertal growth spurt. Bone 2004; 34: 771–775.
33. Richter L, Chevalley T, Manen D et al. Bone mass in prepubertal boys is associated with a Gln223Arg amino acid substitution in the leptin receptor. J Clin Endocrinol Metab 2007; 92: 4380–4386.
34. Sayers A, Timpson NJ, Sattar N et al. Adiponectin and its association with bone mass accrual in childhood. J Bone Miner Res 2010; 25: 2212–2220.
35. Suzuki N, Somei M, Kitamura K et al. Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: Implications for the treatment of bone disease. J Pineal Res 2008; 44: 326–334.
36. Thomas T. The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol 2004; 4: 295–300.
37. Tsuji K, Maeda T, Kawane T et al. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1α,25-dihydroxyvitamin D3 in leptin-deficient mice. J Bone Miner Res 2010; 25: 1711–1723.
38. Venken K, Movérare-Skrtic S, Kapchick JL et al. Impact of androgens, growth hormone, and IGF-I on bone and muscle in male mice during puberty. J Bone Miner Res 2007; 22: 72–82.
39. Žofková I. Hormonal aspects of the muscle-bone unit. Physiol Res 2008; 57 (Suppl 1): S159–S169.
40. Žofková I, Hill M. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women. Edocr Regul 2008; 42: 121–128.
41. Zoico E, Zamboni M, Di Francesco V et al. Relation between adiponectin and bone mineral density in elderly postmenopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. J Endocrinol Invest 2008; 31: 297–302.